<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Antibiotic lock solutions for adjunctive treatment of tunneled hemodialysis catheter-related blood stream infection (CRBSI)</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Antibiotic lock solutions for adjunctive treatment of tunneled hemodialysis catheter-related blood stream infection (CRBSI)</h1>
<div class="graphic"><div class="figure"><div class="ttl">Antibiotic lock solutions for adjunctive treatment of tunneled hemodialysis catheter-related blood stream infection (CRBSI)</div><div class="cntnt"><table cellspacing="0"><colgroup span="4" width="14%"></colgroup><colgroup width="44%"></colgroup> <tbody> <tr> <td class="subtitle1" colspan="4">Volume of components (mL)*</td> <td class="subtitle1" rowspan="2">Final concentration</td> </tr> <tr> <td class="subtitle2">Vancomycin<br/> 5 mg/mL</td> <td class="subtitle2">Ceftazidime<br/> 10 mg/mL</td> <td class="subtitle2">Cefazolin<br/> 10 mg/mL</td> <td class="subtitle2">Heparin<sup>¶</sup><br/> 1000 units/mL</td> </tr> <tr> <td class="subtitle2_left" colspan="5">Vancomycin-ceftazidime-heparin lock</td> </tr> <tr class="divider_bottom"> <td class="centered">1</td> <td class="centered">0.5</td> <td class="centered">0</td> <td class="centered">0.5</td> <td> <ul> <li>2.5 mg/mL vancomycin </li> <li>2.5 mg/mL ceftazidime </li> <li>250 units/mL heparin </li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="5">Vancomycin-heparin lock</td> </tr> <tr class="divider_bottom"> <td class="centered">1</td> <td class="centered">0</td> <td class="centered">0</td> <td class="centered">1</td> <td> <ul> <li>2.5 mg/mL vancomycin </li> <li>500 units/mL heparin </li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="5">Ceftazidime-heparin lock</td> </tr> <tr class="divider_bottom"> <td class="centered">0</td> <td class="centered">1</td> <td class="centered">0</td> <td class="centered">1</td> <td> <ul> <li>5 mg/mL ceftazidime </li> <li>500 units/mL heparin </li> </ul> </td> </tr> <tr> <td class="subtitle2_left" colspan="5">Cefazolin-heparin lock</td> </tr> <tr> <td class="centered">0</td> <td class="centered">0</td> <td class="centered">1</td> <td class="centered">1</td> <td> <ul> <li>5 mg/mL cefazolin </li> <li>500 units/mL heparin </li> </ul> </td> </tr> </tbody></table></div><div class="graphic_lgnd">Antibiotic lock solution is instilled ("locked") into each catheter lumen at the end of each dialysis session instead of standard heparin lock, as an adjunct to systemic antimicrobial therapy, until the catheter is replaced. For antibiotic lock therapy indications and antibiotic component selection, refer to the UpToDate review of tunneled hemodialysis catheter-related bacteremia.</div><div class="graphic_footnotes">* Antibiotic solution components are prepared with normal saline diluent and mixed in a single syringe immediately before instillation using aseptic methods according to local standards. Stability data are provided separately in an UpToDate table of antibiotic lock solutions for non-hemodialysis CRBSIs.<br/>¶ If the patient has a history of or active heparin-induced thrombocytopenia, substitute normal saline for heparin. If the volume of the catheter lumen exceeds 2 mL, the difference in volume should be made up with additional heparin or normal saline.</div><div class="graphic_reference">Adapted from: Allon M. Treatment guidelines for dialysis catheter-related bacteremia: an update. Am J Kidney Dis 2009; 54:13.<br/>Additional data from: Lexicomp Online. Copyright © 1978-2024 Lexicomp, Inc. All rights reserved.</div><div id="graphicVersion">Graphic 126614 Version 6.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
